ライフサイエンスコーパス: perioperative

1 To determine the cost-effectiveness of perioperative administration of pasireotide for reductio

2 tic model was developed to compare costs for perioperative administration of pasireotide versus no pa

3 ife- or vision-threatening intraoperative or perioperative AEs.

4 rast to other patient cohorts, mild forms of perioperative AKI are of subordinate influence on patien

5 ediatric cardiac surgery and to determine if perioperative AKI is associated with worse long-term kid

6 Perioperative AKI is common in patients undergoing vascu

7 Perioperative AKI is not associated with these complicat

8 e 3646 patients undergoing vascular surgery, perioperative AKI occurred in 1801 (49.4%) and CKD was p

9 We investigated the effect of perioperative AKI on 1-year mortality after HTX over a p

10 Perioperative AKI, presence of CKD, and overall and caus

11 of strategies now available to help prevent perioperative AKI.

12 3455 NARCOS cases referred with a suspected perioperative allergic reaction.

13 pare self-declared UK practice in specialist perioperative allergy services with national recommendat

14 urvival analyses assessed the association of perioperative allogeneic blood transfusion, sepsis, and

15 ons Advisory Service) investigates suspected perioperative anaesthetic reactions using serial tryptas

16 ative setting analyses of cases of suspected perioperative anaphylaxis during general anaesthesia (GA

17 Specialist perioperative anaphylaxis services were surveyed through

18 , PPV with a moderate NPV and sensitivity in perioperative anaphylaxis.

19 d OIH without diminishing antinociception in perioperative and chronic pain models.

20 n age, 61.4 years; 54.5% female), the use of perioperative and in-hospital VTE chemoprophylaxis incre

21 Objective: To delineate perioperative and long-term outcomes after CEA in dialys

22 ox regression analyses were used to evaluate perioperative and long-term outcomes.

23 ess weight loss but have substantially lower perioperative and longer-term risk.

24 ome measure was overall survival; short-term perioperative and oncologic outcomes encompassing margin

25 This study aims to compare the perioperative and oncological outcomes of laparoscopic a

26 Perioperative and postoperative complications were repor

27 delivery increases the risk of reoperation, perioperative and postoperative complications, and blood

28 Reoperation, perioperative and postoperative complications, and blood

29 seemed safe, with low frequencies of serious perioperative and postoperative complications.

30 o describe updated organ selection policies, perioperative and postoperative management strategies, m

31 Preoperative, perioperative, and postoperative clinical and laboratory

32 Short-term perioperative Ang1 supplementation may also have therape

33 Perioperative antibiotic administration.

34 The optimal perioperative antibiotic prophylactic regimen in this hi

35 this Review, we outline the data supporting perioperative antibiotic prophylaxis for clean-contamina

36 measures, including extended broad-spectrum perioperative antibiotic treatment, should be considered

37 The predominant perioperative antibiotics used at institutions A, B, and

38 controversy regarding the optimal choice of perioperative antibody induction in KTX to improve outco

39 Perioperative antimicrobial prophylaxis is administered

40 The optimal regimen for perioperative antimicrobial prophylaxis is controversial

41 13 and who received planned manual review of perioperative antimicrobial prophylaxis regimen and manu

42 cussion of practical strategies for managing perioperative antiplatelet therapy in patients following

43 lecular-weight heparin for the prevention of perioperative arterial thromboembolism and would be supe

44 dministration may provide a novel method for perioperative assessment of the effectiveness of carotid

45 tients undergoing cardiac surgery, high-dose perioperative atorvastatin treatment compared with place

46 ng as defined by the Universal Definition of Perioperative Bleeding (UDPB) and E-CABG bleeding classi

47 as associated with an increased frequency of perioperative bleeding complications.

48 surgery in which it was not (e.g., CABG) and perioperative bleeding increased the risk of RAO.

49 Perioperative bleeding is a potentially devastating comp

50 Perioperative bleeding, aortic and mitral valve surgery,

51 ed as a potential modifiable risk factor for perioperative bleeding.

52 Perioperative blood transfusions are associated with inf

53 Perioperative blood transfusions are associated with sho

54 rs of contemporary practice, a trend of less perioperative blood transfusions for oncologic abdominal

55 In contrast, short-term perioperative BowAng1 (a recombinant Ang1 variant) impro

56 blood management (PBM) programs represent a perioperative bundle of care that aim to reduce or elimi

57 For patients with a perioperative capsular rupture of the lens (the major ri

58 of cefuroxime and its use for patients with perioperative capsular rupture where the risk of POE is

59 E and is safe for patients with or without a perioperative capsular rupture.

60 Advances in perioperative cardiac management and an increase in the

61 Previous studies have observed high rates of perioperative cardiovascular events in patients with cor

62 To evaluate national trends in perioperative cardiovascular outcomes and mortality afte

63 A colectomy perioperative care bundle in Michigan is associated with

64 We will expand efforts to implement perioperative care bundles in Michigan to improve outcom

65 Perioperative care bundling has been designed to improve

66 Further inquiry into why advanced perioperative care did not reduce cardiac complications

67 Increasing experience and advances in perioperative care have led to improvement in outcomes.

68 tive psychiatric morbidity should be part of perioperative care in complex cancer patients.

69 To assess the value of bundling perioperative care measures in colon surgery.

70 Despite advances in perioperative care of the recipient, RHF persists as a c

71 Improvement of perioperative care outside the acute hospital setting an

72 Efforts to standardize perioperative care, and thus minimize FTR, will have val

73 After Surgery (ERAS) is a paradigm shift in perioperative care, resulting in substantial improvement

74 and where possible patients should be given perioperative chemoradiotherapy.

75 atively resected gastric cancer treated with perioperative chemotherapy is unknown.

76 tients with locally advanced disease receive perioperative chemotherapy or chemoradiotherapy.

77 pants who were treated with surgery alone or perioperative chemotherapy plus surgery for operable gas

78 receive additional treatment in the form of perioperative chemotherapy, is complex.

79 th poor outcome in UCC patients who received perioperative chemotherapy.

80 iopsies could be used to select patients for perioperative chemotherapy.

81 ppropriate use and timing of colonoscopy for perioperative clearing and for postoperative prevention

82 g a PBM program on transfusion practices and perioperative clinical outcomes.

83 Starting in 2012, a standardized perioperative clinical pathway was introduced, which foc

84 Standardized perioperative cognitive assessment is needed to enable p

85 4.3%) and of older age (mean age, 81 years), perioperative communication with the vitreous (17.9%), e

86 ints were the rates of operative success and perioperative complications (infection and recurrence),

87 in the costs of care for patients surviving perioperative complications after major inpatient surger

88 y checklists (SSCs) reduces the incidence of perioperative complications and 30-day mortality of pati

89 Severe perioperative complications and death are rare, but vary

90 tudies are needed to determine the causes of perioperative complications and identify potential modif

91 on index, which uses a formula combining all perioperative complications and their severities into a

92 Costs associated with rescuing patients from perioperative complications are poorly characterized.

93 l, graft function, operative parameters, and perioperative complications are reported in patients wit

94 In the United States, reports about perioperative complications associated with bariatric su

95 In a high volume institution, major perioperative complications from pancreatic resection we

96 r hospitals to target efficient treatment of perioperative complications in cost-reduction efforts.

97 Incidence of preoperative risk factors and perioperative complications in each group were analyzed.

98 ents who died vs patients who survived after perioperative complications occurred.

99 Reducing perioperative complications or comorbidities by 50% resu

100 coronary artery surgery and were at risk for perioperative complications to receive aspirin or placeb

101 coronary-artery surgery and were at risk for perioperative complications to receive aspirin or placeb

102 Perioperative complications, allograft survival, and pat

103 Cigarette smoking is a risk factor for many perioperative complications, including surgical site inf

104 Because of concerns for perioperative complications, many centers avoid transpla

105 ials suggest superiority of the PG regarding perioperative complications.

106 e episode payments for patients rescued from perioperative complications.

107 ficant reductions in operative mortality and perioperative complications.

108 Perioperative data for patients who underwent postlearni

109 s given access to a dedicated website, where perioperative data were prospectively collected.

110 gative tests is comparable to outpatient and perioperative data.

111 94-0.97) driven by a decline in frequency of perioperative death (aOR, 0.79; 95% CI, 0.77-0.81) and A

112 ependent factor related to increased risk of perioperative death after LT.

113 Perioperative decolonization of Staphylococcus aureus na

114 Main outcome measures included demographics, perioperative details, wound complications, and recurren

115 arrest, and are associated with significant perioperative disability, and risks of morbidity and mor

116 Guidelines for investigation of perioperative drug allergy exist, but the quality of ser

117 The risk of OP-DVT is higher than that of perioperative DVT after colorectal surgery and preoperat

118 l experienced increasing overcrowding of the perioperative environment in 2008.

119 ional Chemotherapy (MAGIC) trial established perioperative epirubicin, cisplatin, and fluorouracil ch

120 hageal cancer randomized to surgery alone or perioperative epirubicin, cisplatin, and fluorouracil ch

121 It reduces perioperative errors and the number of angiograms requir

122 orted outcomes are not correlated with early perioperative events, but are correlated with measures o

123 ment that minimizes stress, and enhances the perioperative experience.

124 analyses to evaluate clinicopathological and perioperative factors for associations with major compli

125 ncidence of SSI stratified over baseline and perioperative factors was compared and compounded in a r

126 Furthermore, we address the role of perioperative factors, including anesthesia, transfusion

127 enhanced recovery care protocols, optimized perioperative fluid administration may be associated wit

128 fluence of liberal (LIB) vs restricted (RES) perioperative fluid administration on morbidity followin

129 There were 2 (4%) and 0 cases of perioperative fluid misdirection syndrome, respectively.

130 s standard practice, which may contribute to perioperative fluid overloading.

131 mization to a LIB (n = 164) or RES (n = 166) perioperative fluid regimen.

132 output of 0.5 mL/kg is a key target guiding perioperative fluid therapy.

133 Perioperative haemorrhage negatively affects patient out

134 Unplanned perioperative healthcare utilization is a significant bu

135 In patients who required perioperative hemodynamic support after cardiac surgery,

136 -controlled trial involving patients in whom perioperative hemodynamic support was indicated after ca

137 may provide a promising therapy for reducing perioperative hemorrhage in elective surgeries.

138 as potential preventive therapy for reducing perioperative hemorrhage in the rodent model of surgical

139 Outcomes measured included perioperative hemorrhage, death, and stroke, and electro

140 ting fibrinogen levels, ultimately improving perioperative hemostasis during SBI.

141 Purpose To investigate whether perioperative hepatic arterial infusion pump chemotherap

142 Perioperative, histopathologic, and long-term data were

143 Perioperative hypotension is associated with an increase

144 Complications of perioperative hypothermia include coagulopathy and incre

145 as the potential to be a diagnostic tool for perioperative identification of LNM and compares favorab

146 Perioperative increase of NT-proBNP has been demonstrate

147 After perioperative inflammation subsided, donor-specific allo

148 0.87; 95% CI, 0.84-0.89) but an increase in perioperative ischemic stroke from 0.52% in 2004 to 0.77

149 jor noncardiac surgery in the United States, perioperative ischemic stroke increased over time.

150 controlled trial aimed to determine whether perioperative IV iron reduced the need for ABT.

151 Administration of perioperative IV iron reduces the need for blood transfu

152 Perioperative lung-protective ventilation has been recom

153 Perioperative MACCE (primary outcome), defined as in-hos

154 ients 56.60%]) for major noncardiac surgery, perioperative MACCE occurred in 317479 hospitalizations

155 Perioperative MACCE occurs in 1 of every 33 hospitalizat

156 ary stent implantation and the occurrence of perioperative major adverse cardiac and cerebrovascular

157 n overview of magnetic resonance imaging and perioperative management among patients with cardiac pac

158 ta related to NOAC reversal for bleeding and perioperative management are sparse, and recommendations

159 However, information concerning perioperative management in these patients is lacking.

160 ecent improvements in surgical practices and perioperative management may have changed these dogmas.

161 as been a major change in how we think about perioperative management of anticoagulation.

162 nstitutions should adopt a NOAC reversal and perioperative management protocol developed with multidi

163 lso underscores unique situations, including perioperative management, intensive care unit management

164 of patients with cirrhosis, thus challenging perioperative management.

165 Similarly, advances in the perioperative medical management of patients, particular

166 processes (internal mammary artery graft and perioperative medications use).

167 Perioperative MI has a markedly high mortality rate, des

168 To determine whether a low perioperative minimum urine output target is safe and fl

169 ndently associated with an increased risk of perioperative morbidity (Relative Risk 1.20, P = 0.03).

170 ndently associated with an increased risk of perioperative morbidity (Relative Risk 1.20, P = 0.03).

171 ansfused packed red blood cell (PRBC) age on perioperative morbidity among patients undergoing major

172 ls and observational studies have shown that perioperative morbidity and mortality are lower with end

173 r events (MACCE) are a significant source of perioperative morbidity and mortality following noncardi

174 Perioperative morbidity and mortality of pancreatoduoden

175 n-free survival and are associated with less perioperative morbidity and mortality.

176 Outcomes included perioperative morbidity and mortality.

177 ion of allogeneic transfusion with increased perioperative morbidity and possibly poorer long-term on

178 eadmitted patients had a higher incidence of perioperative morbidity during the index hospitalization

179 is associated with a significant increase in perioperative morbidity in patients undergoing CRS/HIPEC

180 Perioperative morbidity, use of adjuvant therapy, and lo

181 erformed to assess the effect of PRBC age on perioperative morbidity.

182 erformed to assess the effect of PRBC age on perioperative morbidity.

183 on rate (22.7% v 39.7%; P < .001), and lower perioperative mortality (0.6% v 1.1%), but these women w

184 trategy, patients were subjected to risks of perioperative mortality and complications as well as ini

185 at elevated BMI is associated with increased perioperative mortality and increased rates of infectiou

186 CKD severity is an important predictor of perioperative mortality and long-term survival after AAA

187 In accredited centers, perioperative mortality averages 0.3%.

188 Perioperative mortality estimates by subregion ranged fr

189 eased risk of retransplant within 90-days or perioperative mortality in LLG recipients (P = 0.308 and

190 At the national level in Germany, perioperative mortality is higher than anticipated from

191 The perioperative mortality rate for isolated septal myectom

192 Perioperative mortality was twice as high at HBHs (3.7%)

193 Both recipient groups had similar perioperative mortality, 30-day readmission rates, and s

194 al complications of IBDI and their impact on perioperative mortality, graft, and patient survival aft

195 differences in complications, hospital stay, perioperative mortality, or median survival compared to

196 Sensitivity analyses exploring variable perioperative mortality, rate of PF/PL/A, and readmissio

197 vere aortic stenosis who are at high risk of perioperative mortality.

198 prevent postoperative atrial fibrillation or perioperative myocardial damage in patients undergoing e

199 percutaneous coronary intervention (PCI) in perioperative myocardial infarction (PMI), even though P

200 e period, but there was an increased rate of perioperative myocardial infarction during the study per

201 0, renal-replacement therapy through day 30, perioperative myocardial infarction through day 5, or us

202 s to the potential risk of stent thrombosis, perioperative myocardial infarction, or both.

203 d point of death, renal-replacement therapy, perioperative myocardial infarction, or use of a mechani

204 Perioperative myocardial injury (PMI) seems to be a cont

205 Perioperative necessity of deep sedation is inevitably a

206 rch 2014 from the PIONEER intraoperative and perioperative OCT study were included.

207 Hence, perioperative Omegaven may provide an easy and controlla

208 (iOCT) in the Prospective Intraoperative and Perioperative Ophthalmic Imaging with Optical Coherence

209 For patients filling a perioperative opioid prescription, we calculated the inc

210 Secondary endpoints comprised perioperative outcome and pancreatic function and qualit

211 This constituted five perioperative outcome domains (including anastomotic lea

212 en associated with increased risk of adverse perioperative outcome in adults undergoing cardiac surge

213 BMI represents a modifiable risk factor for perioperative outcome.

214 ning curve RPD can be performed with similar perioperative outcomes achieved with OPD.

215 as improving functional status, may improve perioperative outcomes and decrease readmissions.

216 ies have proclaimed a general improvement of perioperative outcomes following pancreatic surgery.

217 ed prognostic score for ICC and to determine perioperative outcomes for large multifocal ICCs or tumo

218 (ICC), the oncologic benefit of surgery and perioperative outcomes for large multifocal tumors or tu

219 The effect of BMI on perioperative outcomes in congenital heart disease patie

220 cal infiltration of liposomal bupivacaine on perioperative outcomes in patients undergoing primary TK

221 ased surgical safety checklists in improving perioperative outcomes in research trials, effective met

222 ior outcomes and higher costs, and improving perioperative outcomes may have a nominal effect on redu

223 We performed a multicenter comparison of perioperative outcomes of robotic PD (RPD) and open PD (

224 Risk-adjusted perioperative outcomes were also assessed.

225 Risk-adjusted perioperative outcomes were also assessed.

226 RBCs, clinicopathologic characteristics, and perioperative outcomes were obtained and analyzed.

227 RBCs, clinicopathologic characteristics, and perioperative outcomes were obtained and analyzed.

228 t on dialysis, is associated with acceptable perioperative outcomes, patient survival, and slightly w

229 treated at high-volume centers had improved perioperative outcomes, short-term mortality, and overal

230 with higher healthcare utilization and worse perioperative outcomes.

231 ions of operative approach (RPD or OPD) with perioperative outcomes.

232 FFP and platelets are associated with poorer perioperative outcomes.

233 l teaching intensity, Medicare payments, and perioperative outcomes.

234 Frail patients are known to have poor perioperative outcomes.

235 sed attention and intervention for improving perioperative outcomes.

236 rding to their needs would be beneficial for perioperative pain and perhaps obviate the need for oral

237 program designed with a particular focus on perioperative pain management, mobility, nutrition, and

238 Reported outcomes include perioperative parameters, defibrillation testing, and cl

239 n of clinically significant POPF with use of perioperative pasireotide in patients undergoing pancrea

240 Perioperative perforation was also associated with an in

241 utcome was WHO grade 3 bleeding in the early perioperative period (from entry into the operating room

242 ients with lung cancer were drawn during the perioperative period and assessed for CTC burden using a

243 ious strategies for managing DAPT during the perioperative period have been proposed.

244 The perioperative period is characterized by an increased ri

245 essary to improve cardiovascular care in the perioperative period of patients undergoing noncardiac s

246 The majority of patient deaths after the perioperative period were not attributable to right vent

247 After median cell loss of 32% in the perioperative period, ECD declined at a linear rate of a

248 may also have important implications in the perioperative period, in which the use of novel oral ant

249 Transfusion rates were calculated for the perioperative period, which was defined as the time from

250 ological therapy during the preoperative and perioperative periods were evaluated in association with

251 ed hepatocarcinogenesis in Mdr2(-/-) mice by perioperative pharmacological inhibition of interleukin-

252 superficial SSI, even in patients receiving perioperative piperacillin-tazobactam.

253 and associated surgical risks; if indicated, perioperative plans were modified based on team input.

254 l cell carcinoma (UCC) is surgery along with perioperative platinum-based chemotherapy.

255 Cataract surgery patients who had a perioperative prescription of topical NSAIDs filled in a

256 patient counseling and guide application of perioperative pulmonary optimization measures.

257 rimary graft dysfunction was the predominant perioperative risk factor for 1-year mortality.

258 Women with a high perioperative risk profile or a low likelihood of achiev

259 uled for elective cardiac surgery to receive perioperative rosuvastatin (at a dose of 20 mg daily) or

260 aim of increasing the antitumor response of perioperative RT, these agents may even be combined with

261 lls from healthy volunteers were cultured in perioperative serum and CD14Human Leukocyte Antigen-DR (

262 A marked variation of perioperative serum Na remains the main risk factor even

263 tients experienced higher intraoperative and perioperative serum Na/24 hr variations compared to cont

264 To validate consensus equation in a perioperative setting analyses of cases of suspected per

265 ho might have been previously treated in the perioperative setting, including platinum-naive patients

266 enges and opportunities, most notably in the perioperative setting.

267 cs, cardiac output, and stroke volume in the perioperative setting.

268 den epidemic of cognitive dysfunction in the perioperative setting.

269 The primary endpoint was the occurence of perioperative severe critical events requiring immediate

270 The incidence of perioperative severe critical events was 5.2% (95% CI 5.

271 To determine whether a perioperative, standardized clinical pathway could impac

272 small randomized trials have suggested that perioperative statin therapy can prevent some of these c

273 In this trial, perioperative statin therapy did not prevent postoperati

274 However, perioperative stroke and death were substantially less c

275 Predictors of perioperative stroke were symptomatic status (odds ratio

276 ath, or subsequent ipsilateral stroke and 2) perioperative stroke, death, or any subsequent stroke.

277 , carotid endarterectomy reduced rates of 1) perioperative stroke, death, or subsequent ipsilateral s

278 increased rate of grade A/B bleeding events, perioperative stroke, less enzyme supplementation at 6 m

279 sures: The primary outcomes of interest were perioperative stroke, myocardial infarction and mortalit

280 Novel approaches to perioperative surgical care focus on optimizing nutritio

281 (ie, storage duration before transfusion) on perioperative surgical outcomes remains poorly defined.

282 (ie, storage duration before transfusion) on perioperative surgical outcomes remains poorly defined.

283 We have achieved a perioperative survival rate close to 100%.

284 ons remains hypothetical, measures to reduce perioperative suture colonization may minimize postopera

285 All patients who received HAI also received perioperative systemic chemotherapy.

286 gery (ERAS) program by the multidisciplinary perioperative team responsible for the care of elective

287 on, compared with placebo, administration of perioperative THR-184 through a range of dose exposures

288 ose comparison of the safety and efficacy of perioperative THR-184 using a two-stage seamless adaptiv

289 When used for perioperative thromboprophylaxis, there are no differenc

290 Restrictive perioperative transfusion practices are a possible strat

291 A perioperative urine output target of 0.2 mL/kg/h is noni

292 as difficult, and lacked knowledge about the perioperative use of advance directives.

293 Perioperative variables as well as microbiology data for

294 sociation of PPCs with ventilatory and other perioperative variables.

295 e analyzed their association with modifiable perioperative variables.

296 h eye undergoing cataract surgery including: perioperative visual acuity, copathologic features, simu

297 s when assigning financial disincentives for perioperative VTE.

298 Uninterrupted perioperative warfarin therapy is safe for patients unde

299 ve hip or knee arthroplasty and treated with perioperative warfarin, genotype-guided warfarin dosing,

300 utic approaches to target the protumorigenic perioperative window and ultimately improve long-term on